Effect of oral conjugated estrogen compared with cryoprecipitate to prevent bleeding in patients with renal failure candidates for kidney biopsy

Research Deputy of Ahvaz University of Medical Science and Health science0 个研究点目标入组 30 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•Patients with renal insufficiency (creatinine greater than 3 mg/dL) who are candidates for biopsy
•Exclusion criteria:
•1.Pregnant women, or women who suspect pregnancy and ways to avoid becoming pregnant to leave have
•2.Lactating women
•3.Patients with a history of thromboembolism
•4.Any of the patients treated with anticoagulant or platelet aggregation inhibitors such as warfarin, heparin, enoxaparin, Ticlopidine, clopidogrel, and statins and their agents can not be stopped
•5.Patients who are treated with NSAIDs and their agents can not be interrupted for any reason
•6.Patientswho have clotting disorders (such as patients with hemophilia) or in the laboratory of PT> 14, PTT> 35, or INR> 1.5
•7.Patients who were under a regime of hard power (such as prolonged fasting or water treatment) and lack of essential Elements, vitamins such as vitamin C or K in the body there
•8.Patients who have blood pressure higher than 160/100,before the biopsy
•9.Patients with a creatinine level is less than 3 milligrams per deciliter
•10.Patients who are suffering from liver cirrhosis.
•11.Patients with platelet count less than 100,000
•12.Patients who have cysts in both kidney
•13.Patients who have undergone kidney transplant
•14.Patients who are diagnosed with breast cancer
•15.Patients who have a history of stroke and myocardial infarction
•16.Patients who are unexplained uterine bleeding
•17.Patients who have a history of sensitivity to estrogen compounds

发起方

Research Deputy of Ahvaz University of Medical Science and Health science